Book Review: ‘In the Blood,’ by Charles Barber
“In the Blood” traces how an engineer and a salesman took on military leaders and Big Pharma to get a revolutionary clotting agent to those in dire need.
“In the Blood” traces how an engineer and a salesman took on military leaders and Big Pharma to get a revolutionary clotting agent to those in dire need.
A tornado that damaged a Pfizer plant in North Carolina will likely limit supplies of pain relievers used in surgery and other critical-care drugs.
The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.
Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents show.
A quarter of insured adults report delayed or missed medical care because of administrative tasks.
Extensive damage occurred at the company’s property in Rocky Mount, and many products used by hospitals appeared to have been affected. This could further exacerbate shortages.
The availability of the pill without a prescription could significantly expand access to contraception.
One brand of oral contraceptive will soon be available on pharmacy shelves. What else could follow?
The respiratory virus is a global killer of babies and young children.
A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.